Bioabsorbable Nano-Micelle Hybridized Hydrogel Scaffold Prevents Postoperative Melanoma Recurrence
March 2023
in “
Journal of controlled release
”
New to Hyaluronic Acid? There is a guide in the encyclopedia. Read the guide → 
Studysummary This study reports that a novel bioabsorbable nano-micelle hybridized hydrogel scaffold may reduce postoperative melanoma recurrence and mitigate the side effects of doxorubicin in mouse models.
Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
In this study, researchers developed a bioabsorbable nano-micelle hybridized hydrogel scaffold (HGMP) for local chemotherapy after tumor surgery. The scaffold, made from derivatives of gelatin and hyaluronic acid, integrates doxorubicin-loaded nano-micelles (PP/DOX) via a click reaction, allowing for long-term drug release and rapid degradation under enzymatic conditions. This targeted delivery system effectively reduces local toxicity and clears residual tumors, providing a promising approach to prevent postoperative melanoma recurrence. The study demonstrated good tumor-targeted properties both in vitro and in vivo, highlighting the potential of HGMP in enhancing postoperative cancer therapy.
